Vincenza Conteduca Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Biography Publications Institution JoVE Articles Vincenza Conteduca has not added a biography. If you are Vincenza Conteduca and would like to personalize this page please email our Author Liaison for assistance. Publications Circulating Androgen Receptor Combined with 18F-fluorocholine PET/CT Metabolic Activity and Outcome to Androgen Receptor Signalling-directed Therapies in Castration-resistant Prostate Cancer Scientific Reports. Nov, 2017 | Pubmed ID: 29138500 Cell-free DNA As a Diagnostic Marker for Cancer: Current Insights OncoTargets and Therapy. 2016 | Pubmed ID: 27822059 Systemic Immune-inflammation Index Predicts the Clinical Outcome in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib Oncotarget. 08, 2016 | Pubmed ID: 27409344 Circulating AR Copy Number and Outcome to Enzalutamide in Docetaxel-treated Metastatic Castration-resistant Prostate Cancer Oncotarget. Jun, 2016 | Pubmed ID: 27191887 Early Outcome Prediction on 18F-fluorocholine PET/CT in Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Oncotarget. Dec, 2014 | Pubmed ID: 25504434 Siero e Plasma copia numero rilevazione mediante PCR in tempo reale Samanta Salvi1, Vincenza Conteduca1, Filippo Martignano1, Giorgia Gurioli1, Daniele Calistri1, Valentina Casadio1 1Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 56502 Cancer Research
Siero e Plasma copia numero rilevazione mediante PCR in tempo reale Samanta Salvi1, Vincenza Conteduca1, Filippo Martignano1, Giorgia Gurioli1, Daniele Calistri1, Valentina Casadio1 1Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 56502 Cancer Research
